The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.

Researchers also found these effects can be reversed by treatment with an antioxidant.

Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.

The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.

Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.

Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

These bacteria, which could be designed to detect pollution or nutrients, could act as sensors to help farmers monitor their crops.

The research may enable the design of synthetic, light-activated cells for wound healing or drug delivery.

MIT engineers developed a way to grow artificial tissues that look and act like their natural counterparts.